← Back to Archive

September 3, 2024

HNF participates in inaugural Critical Path Institute (C-Path) Global Impact Conference in Washington

Hereditary Neuropathy Foundation logo Allison Moore, Founder/CEO will participate in the the session, titled “Navigating the Patient-Focused Drug Development Roadmap.” NEW YORK, NEW YORK , UNITED STATES...